Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Return on Equity (2021 - 2025)

Historic Return on Equity for Trinity Biotech (TRIB) over the last 5 years, with Q2 2025 value amounting to 0.66%.

  • Trinity Biotech's Return on Equity fell 1900.0% to 0.66% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.66%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 0.02% for FY2024, which is 10000.0% up from last year.
  • Per Trinity Biotech's latest filing, its Return on Equity stood at 0.66% for Q2 2025, which was down 1900.0% from 1.01% recorded in Q4 2024.
  • Over the past 5 years, Trinity Biotech's Return on Equity peaked at 104.03% during Q3 2021, and registered a low of 80.8% during Q2 2021.
  • In the last 5 years, Trinity Biotech's Return on Equity had a median value of 1.01% in 2024 and averaged 0.76%.
  • Examining YoY changes over the last 5 years, Trinity Biotech's Return on Equity showed a top increase of 755100bps in 2022 and a maximum decrease of -1073300bps in 2022.
  • Trinity Biotech's Return on Equity (Quarter) stood at 13.28% in 2021, then crashed by -250bps to 19.9% in 2022, then surged by 109bps to 1.79% in 2023, then tumbled by -44bps to 1.01% in 2024, then tumbled by -35bps to 0.66% in 2025.
  • Its Return on Equity stands at 0.66% for Q2 2025, versus 1.01% for Q4 2024 and 0.73% for Q3 2024.